NDC properties for "Betimol 0.25 % Ophthalmic Solution" (RxCUI 208560)
About this data
The tables show NDC propoerties for Betimol 0.25 % Ophthalmic Solution with the RxCUI 208560
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Betimol 0.25 % Ophthalmic Solution (RxCUI 208560)
| MMSL_CODE | BD3324 |
|---|---|
| NDA | NDA020439 |
| RxCUI | 208560 |
| SPL_SET_ID | 00f62dd1-dad2-4892-8a5d-21e5e54509ce |
| SPL_SET_ID | 3ae775f4-340c-4bf4-aa49-8a31daba0f8b |
| SPL_SET_ID | 3d7acd55-33b1-4a24-99ae-01f87b0dca1f |
| Prescribable Synonym | BETIMOL 0.25 % Ophthalmic Solution |
| RXNAV_STR | Betimol 0.25 % Ophthalmic Solution |
| RxNorm Name | timolol hemihydrate 2.5 MG/ML Ophthalmic Solution [Betimol] |
| RxNorm Synonym | Betimol 0.25 % Ophthalmic Solution |
| RxNorm Synonym | Betimol 2.5 MG/ML (as timolol hemihydrate 2.56 MG/ML) Ophthalmic Solution |
| RxNorm Synonym | Betimol 2.5 MG/ML Ophthalmic Solution |
| Related queries | Interactions (for RxCUI 208560) |
NDC Properties
NDC Item 76478000105
| NDC 9 | 76478-001 |
|---|---|
| NDC 10 | 76478-001-05 |
| NDC Item | 76478000105 |
| Packaging | 1 BOTTLE in 1 CARTON (76478-001-05) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 636406 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-01-02 |
| Marketing status | ACTIVE |
| NDA | NDA020439 |
| Related queries | Properties for NDC 9 76478-001 |
NDC Item 82584000105
| NDC 9 | 82584-001 |
|---|---|
| NDC 10 | 82584-001-05 |
| NDC Item | 82584000105 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82584-001-05) / 5 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 783305 |
| Labeler | Thea Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-12-01 |
| Marketing status | ACTIVE |
| NDA | NDA020439 |
| Related queries | Properties for NDC 9 82584-001 |
NDC Item 76478000105
| NDC 9 | 76478-001 |
|---|---|
| NDC 10 | 76478-001-05 |
| NDC Item | 76478000105 |
| Packaging | 1 BOTTLE in 1 CARTON (76478-001-05) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 636406 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-01-02 |
| Marketing status | ACTIVE |
| NDA | NDA020439 |
| Related queries | Properties for NDC 9 76478-001 |
NDC Item 82584000105
| NDC 9 | 82584-001 |
|---|---|
| NDC 10 | 82584-001-05 |
| NDC Item | 82584000105 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (82584-001-05) / 5 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 783305 |
| Labeler | Thea Pharma Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-12-01 |
| Marketing status | ACTIVE |
| NDA | NDA020439 |
| Related queries | Properties for NDC 9 82584-001 |